Fluzone Intradermal vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 18 through 64 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine

Safety Information

Erythema, induration, swelling, and pruritus at the vaccination site occur more frequently with Fluzone Intradermal vaccine than with Fluzone vaccine. Other adverse reactions to Fluzone Intradermal vaccine include pain at the vaccination site; headache, myalgia, and malaise. Adverse reactions other than those listed above may occur. Fluzone Intradermal vaccine should not be administered to anyone with a severe allergic reaction (eg, anaphylaxis) to any vaccine componenent, including egg protein, egg products, or to a previous dose of any influenza vaccine. The decision to give Fluzone Intradermal vaccine should be based on the potential benefits and risks, especially if Guillain-Barré syndrome has occured within 6 weeks of receipt of a prior influenza vaccine. Vaccination with Fluzone Intradermal vaccine may not protect all individuals.

Before administering Fluzone Intradermal vaccine, please see full Prescribing Information.

Fluzone and Fluzone Intradermal vaccines are manufactured and distributed by Sanofi Pasteur Inc.